Testing effectiveness (Phase 2)Study completedNCT00398905
What this trial is testing
Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement
Who this might be right for
Venous Thromboembolism
Bayer 726